Long-term operating lease liability, net of current portion
9,799
10,063
10,308
10,532
Long-term financing lease liability, net of current portion
36
151
259
398
Common stock, 0.001 par value per share 340,000,000 authorized shares as of june 30, 2026 (unaudited) and december 31, 2025 issued and outstanding shares - 98,087,425 as of june 30, 2026 (unaudited) and 98,031,104 as of december 31, 2025
98
98
98
98
Additional paid-in capital
676,022
674,861
673,554
672,339
Accumulated other comprehensive loss
-68
-70
-8
-1
Accumulated deficit
-627,264
-616,955
-606,164
-592,201
Total atyr pharma stockholders equity
48,788
57,934
67,480
80,235
Noncontrolling interest in pangu biopharma limited
-194
-193
-192
-191
Total stockholders' equity
48,594
57,741
67,288
80,044
Total liabilities and stockholders equity
69,825
79,654
93,003
106,652
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.